Shahid Beheshti University of Medical Sciences
  • Register
  • Login
##common.pageHeaderLogo.altText##
  • Home
  • Issues
    • Current
    • Archives
  • Journal Info
    • Aim & Scope
    • Editorial Team
    • Indexing/Abstracting
    • Privacy Statement
    • Contact
  • Journal Policies
    • Open access Policy
    • Pre print Policy
    • Review Policy
    • Using AI Policy
    • APC Policy
    • Plagiarism Policy
  • Publication Ethics
  • Guidelines
    • For Authors
    • Statement of Authorship and Copyright
  • Manuscript Templates
    • Original/Research
    • Case Reports
    • Review Articles
  • Submit Manuscript
  • Announcements
Advanced Search
  1. Home
  2. Archives
  3. Vol. 8 No. 2 (2020): Spring, Covid-19
  4. Reviews
Cover of Journal of

Vol. 8 No. 2 (2020)

June 2020

Continuous Renal Replacement Therapy (CRRT) in Patients with COVID-19 Infection

  • Mastaneh Moghtaderi
  • Fatemeh Ghane Sherbaf

Journal of Pediatric Nephrology, Vol. 8 No. 2 (2020), 2 June 2020 , Page 1-4
https://doi.org/10.22037/jpn.v8i2.30244 Published: 2020-06-02

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

COVID-19, a pandemic caused by a novel coronavirus, in severe cases, it may involve multiple organs including the kidneys. Kidney involvement has been reported in many cases and the most common presentation is with acute kidney injury (AKI) proteinuria and hematuria. The pathogenic mechanism of renal involvement in coronavirus disease 19 (COVID-19) is still unclear. It is supposed to result from a combination of several contributing factors, such as

dehydration, acute tubular necrosis, toxic tubular damage, cytokine storm or rhabdomyolysis. CRRT can use in multiorgan failure and associated by reduce mortality.

 

Keywords: COVID-19; Corona virus disease 2019; CRRT; Child.

  • PDF

How to Cite

1.
Moghtaderi M, Ghane Sherbaf F. Continuous Renal Replacement Therapy (CRRT) in Patients with COVID-19 Infection. J Ped Nephrol [Internet]. 2020 Jun. 2 [cited 2026 Jul. 8];8(2):1-4. Available from: https://journals.sbmu.ac.ir/jpn/article/view/30244
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F. Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin. Wochenschr 1977;55:1121–1122. [CrossRef]

Ronco C, Brendolan A, Bragantini L, Chiaramonte S, Fabris A, Feriani M, et al. Treatment of acute renal failure in the newborn by continuous arteriovenous hemofiltration. Trans. Am. Soc. Artif. Intern. Organs 1985, 31, 634–638.

Goldstein S.L, Somers M.J, Brophy P.D, Bunchman T.E, Baum M, Blowey D, et al. The Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry: Design, development and data assessed. Int. J. Artif. Organs 2005;427:9–14. [CrossRef]

Goldstein S.L, Somers M.J, Baum M.A, Symons J.M, Brophy P.D, Blowey D, et al. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int. 2005;67:653–658. [CrossRef]

Hwa Lee K , Suk Sol I, Tak Park J. Continuous Renal Replacement Therapy (CRRT) in Children and the Specialized CRRT Team: A 14-Year Single-Center Study J. Clin. Med. 2020; 9:110; doi:10.3390/jcm9010110

Assadi F, Ghane Sharbaf F. Pediatric Continues Renal Replacement Therapy. Springer International Publishing Switzerland 2016.

Splendiani G, Mazzarella V, Cipriani S, Zazzaro D, Casciani CU. Continuous renal replacement therapy: our experience in intensive care unit. Ren Fail. 2001; 23: 259-64.

Mu TS, Palmer EG, Batts SG, Lentz-Kapua SL, Uyehara. Goldstein Sl. Continuous renal replacement therapy: mechanism of clearance, fluid removal, indications and outcomes. Current Opinion in Pediatrics, 01 Apr 2011, 23(2):181-185. DOI: 10.1097/mop.0b013e328342fe67.

Gulla K, Sachdev I, Gupta D at all. Continuous renal replacement therapy in children with severe sepsis and multiorgan dysfunction - A pilot study on timing of initiation. Indian J Crit Care Med. 2015 Oct;19(10): 613–617.doi:10.4103/0972-5229.167044.

Zhang Y, Hu W, Zhou L. Continuous renal replacement therapy in children with multiple organ dysfunction syndrome: A case series. Vol. 40 (6): 846-852, November - December, 2014 doi: 10.1590/S1677-5538.IBJU.2014.06.18.

Yizhi Peng, Zhi-Qiang Yuan, Hongbin Li. Removal of inflammatory cytokines and endotoxin by venovenous continuous renal replacement therapy for burned patients with sepsis. Burns 2005;31(5):623-8 DOI: 10.1016/j.burns.2005.02.004.

Sebestyen JF, Warady BA. Advances in pediatric renal replacement therapy. Adv Chronic Kidney Dis. 2011;18: 376-83.

Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JA https://doi.org/10.1001/jama.2020.1585 Accessed March 2, 2020.

Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.

Li Z, Wu M, Guo J, et al. Caution on kidney dysfunctions of 2019-nCoV patients. medRxiv 2020.02. 08.20021212. Accessed March 2, 2020.

Cheng Y, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients [e-pub ahead of print]. medRxiv 2020.02.18.20023242. https://doi.org/10.1101/2020.02.18.20023242.

Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251–254.

Muhammed Mubarak, Hamid Nasri, COVID-19 nephropathy; an emerging condition caused by novel coronavirus infection, J Nephropathol. 2020;9(3):e21, www.nephropathol.com DOI: 10.34172/jnp.2020.21

Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506.

Pedersen, S. F. & Ho, Y. C. A storm is raging. J. Clin. Invest 2020 https://doi.org/10.1172/JCI137647.

Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J, et al. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi 2020;43:E005.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020 Feb 18. doi: 10.1016/S2213-2600(20)30076-X.

National Health Commission, National Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial Version 7). Chin Med J 2020;133. doi: 10.3760/cma.j.issn.0366-6999.2020.0027.

Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents 2020 Mar 11. doi: 10.1016/j.ijantimicag.2020.105938

Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 2020 Feb 7. doi: 10.1038/s41584-020-0372-x.

Ming Zhaoa, Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies, International Journal of Antimicrobial Agents, S0924-8579(20)30139-4 DOI: https://doi.org/10.1016/j.ijantimicag.2020.105982

Yi Yang, Jia Shi, Shuwang Ge, Shuiming Guo, Xue Xing, Yanan Wang, et al. Effect of continuous renal replacement therapy on all-cause mortality in COVID-19 patients undergoing invasive mechanical ventilation: a retrospective cohort study, medRxiv, doi: https://doi.org/10.1101/2020.03.16.20036780

  • Abstract Viewed: 575 times
  • PDF Downloaded: 350 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems

Information

  • For Readers
  • For Authors
  • For Librarians
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Online ISSN (e-ISSN): 2345-3176                                                                  

The "Journal of Pediatric Nephrology" is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. 

 

Powered by OJSPlus